Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe
by Carly Helfand Teva’s layoffs and cost cuts are here—and they’re far larger than reports predicted. The company said Thursday it
Read moreTeva Pharmaceutical
Novartis pushes past manufacturing slowdown to launch second long-acting Copaxone copy
by Carly Helfand | Feb 13, 2018 9:32am Novartis’ copy of Teva’s long-acting Copaxone will be second to market behind
Read moreL'ONU intraprende un primo passo concreto affinché Israele sia ritenuto responsabile per le violazioni dei diritti umani dei palestinesi
L’ONU intraprende un primo passo concreto affinché Israele sia ritenuta responsabile per le violazioni dei diritti umani dei palestinesi
Read moreUN takes first concrete step to hold Israel accountable for violating Palestinian human rights
September 27, 2017 — Today’s media reports revealed that the UN High Commissioner for Human Rights began sending letters two weeks ago to 150
Read moreTeva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
The FDA has nailed another Teva manufacturing facility with a warning letter, this time for an API facility in China.
Read moreTeva woes keep piling up with another investigation for bribery
by Eric Palmer | Feb 7, 2017 3:12pm When it rains it pours, and Teva is experiencing a flood of bad
Read moreStruggling Teva said to plan thousands of job cuts as it hunts for CEO
by Carly Helfand | Mar 23, 2017 10:14am Changes are afoot at foundering Teva—and they include job cuts and a
Read moreTeva CEO Vigodman exits, piling uncertainty onto the struggling drugmaker
by Carly Helfand | Feb 7, 2017 8:15am So long, Erez Vigodman. After a brutal 2016 and start to 2017
Read moreTeva recalls 500,000 units of diabetes drug manufactured by Patheon
by Eric Palmer | Feb 16, 2017 9:39am It is not as if Israeli drugmaker Teva didn’t already have
Read moreTeva faces billions in lost sales as court tosses four long-acting Copaxone patents
by Carly Helfand | Jan 30, 2017 11:34pm It’s déjà vu for Teva Pharmaceutical in a bad, bad way.
Read moreTeva wraps up Cipro pay-for-delay suit inherited with Barr buy
by Eric Sagonowsky | Jan 27, 2017 9:35am Shortly after paying $520 million to the feds to resolve
Read moreFDA cites 'significant' sterility concern at Teva injectables plant
by Eric Palmer | Oct 27, 2016 8:47am The FDA has posted the warning letter that Teva recently acknowledged getting
Read moreUPDATED: Pii produced products recalled by Teva
by Eric Palmer | Oct 20, 2016 9:04am Teva ($TEVA) is recalling nearly 43,000 bottles of paricalcitol, a drug used
Read moreUPDATED: Teva's struggling sterile plant hit with FDA warning letter
by Eric Palmer | Oct 19, 2016 9:34am The regulatory quagmire has deepened for the Teva Pharmaceutical sterile injectables plant
Read moreUPDATED: Teva recalling all lots of 4 drugs made at troubled Hungary plant
by Eric Palmer | Sep 14, 2016 9:32am Teva continues to deal with the fallout from an FDA ban of
Read moreTeva issues another recall of antibiotics, this time from a Canadian plant
by Joseph Keenan | Aug 25, 2016 8:18am For the second time this year, Teva ($TEVA) has issued a recall
Read moreTeva recalls antibiotic made at banned plant in Hungary
by Eric Palmer | Aug 8, 2016 12:40pm When the FDA put Teva’s sterile manufacturing site in Hungary
Read moreTeva recalls seizure drug
by Eric Palmer | Aug 1, 2016 4:43pm Teva Pharmaceutical ($TEVA) has its hands full trying to finalize its
Read moreTeva pulls migraine patch Zecuity on reports of burning, scarring
by Carly Helfand | Jun 13, 2016 9:01am So much for the $114 million Teva shelled out to get its
Read moreTeva halts production at sterile injectables plant to address FDA concerns
by Eric Palmer | Jun 6, 2016 9:49am Teva Gödöllő plant Sterile injectable products are notoriously difficult to produce, and
Read more